Nurix

Director, Nonclinical Toxicology Operations

Nurix$220K — $252K *
Pharmaceuticals & Biotech
8 - 10 years of experience
Job Overview by Ladders

Qualifications

  • M.S. or Ph.D. in life sciences (toxicology, pharmacology, biology, chemistry, or related) required.
  • 10+ years of biotech or pharmaceutical experience, ideally with project management of multidisciplinary programs.
  • Proven track record in managing CROs, budgets, and performance.
  • Experience in IND-enabling activities and nonclinical safety assessments.
  • Familiarity with small molecule drug discovery and development; experience in targeted protein degradation, oncology, or immunology is advantageous.

Responsibilities

  • Partner with study directors to scope and design in vivo and in vitro safety studies.
  • Manage CROs, coordinating bid solicitation and vendor selection processes.
  • Oversee contract lifecycle, including drafting work orders and managing budgets.
  • Build and maintain integrated timelines, monitoring study milestones and report delivery.
  • Run project team meetings, capturing decisions and action items to ensure closure.
  • Maintain program plans and dashboards, surfacing risks with mitigation strategies.
  • Act as a central hub to resolve cross-functional interface issues.

Benefits

  • Strong team-oriented culture with a focus on collaboration.
  • Hands-on approach emphasized, encouraging diverse viewpoints.
  • Opportunities for professional growth within a fast-paced environment.
Full Job Description
Director, Nonclinical Toxicology Operations

Position Summary:

Nurix Therapeutics is seeking a Director of Preclinical Safety and Toxicology Operations to drive planning and execution of nonclinical safety and toxicology activities within our Research and Early Development division. The role will be responsible for operations activities including owning timelines, budgets, contracts, and cross-functional coordination for a portfolio of targeted protein degradation programs. The ideal candidate will be adept at partnering closely with subject matter experts, preclinical Project Leads, clinical Asset Team Leaders, and the SVP of Preclinical Toxicology who will provide oversight and scientific direction.

The role has two complementary halves. The first is operational support to the nonclinical Safety and Toxicology function - helping study directors and toxicology leads scope and design studies, selecting and managing CROs, negotiating and administering contracts, and keeping study execution on schedule and on budget. The second is program-level project management for drug discovery projects as they transition from late lead optimization through IND filing, integrating chemistry, DMPK, pharmacology, safety, CMC, and regulatory timelines into a single credible plan.

You will thrive here if you are highly organized, scientifically fluent, comfortable holding teams and stakeholders to a schedule, and energized by turning complex, interdependent work into clear milestones and decisions.

Key Responsibilities:

Toxicology study support and vendor management
  • Partner with Toxicology Leads and Study Directors to scope, design, and schedule GLP and non-GLP in vivo and in vitro safety studies, including exploratory tox, DRF, GLP repeat-dose toxicology, safety pharmacology, and genetic toxicology.
  • Identify, qualify, and manage CROs and specialty vendors; coordinate bid solicitation, bid defense, and vendor selection in partnership with Toxicology, Procurement, and Legal.
  • Own the contract lifecycle: draft and route work orders, MSAs, change orders, and amendments; track scope changes against budget; reconcile invoices and support accruals and forecasting.
  • Build and maintain integrated study timelines; monitor study milestones, sample logistics, bioanalytical turnaround, and report delivery, escalating slippage early with options rather than surprises.
  • Coordinate protocol and report review cycles, ensuring documents move efficiently through internal review, QA, and sign-off.
  • Track deliverables required for regulatory submissions, including study reports, certificates of analysis, and test article documentation.
  • Demonstrated ability to ensure safety issues are communicated rapidly and with appropriate escalation to the drug safety/project team, leadership and relevant agencies.

Program management, late lead optimization to IND
  • Serve as project manager for assigned discovery and development programs from late lead optimization through candidate selection, IND-enabling studies, and IND filing.
  • Develop and maintain integrated program plans, critical paths, and resource views spanning medicinal chemistry, analytical chemistry, computational chemistry, DMPK, pharmacology, toxicology, CMC, and regulatory.
  • Run project team meetings: set agendas, capture actions and decision rationale in meeting minutes, and follow through to closure.
  • Maintain program dashboards, milestone trackers, and risk registers; surface risks with mitigation and contingency plans.
  • Prepare materials and pre-reads for portfolio reviews, governance meetings, and leadership updates; ensure a single, consistent version of program status.
  • Coordinate scenario and what-if planning to support go/no-go decisions, candidate selection, and IND timing.

Cross-functional leadership and process
  • Act as a connective hub across functions and sites, resolving interface issues before they become timeline issues.
  • Contribute to continuous improvement of project management practices, templates, and tools within the group.

Qualifications:

Education
  • Required: M.S. or Ph.D. in a life sciences discipline (toxicology, pharmacology, biology, chemistry, pharmaceutical sciences, or related).
  • Preferred: formal project management credential such as PMP.

Experience
  • Typically, 10+ years of relevant biotech or pharmaceutical experience, including demonstrable project management ownership of multidisciplinary programs.
  • Track record managing CROs and external vendors, including contracting, budget tracking, and performance management.
  • Direct experience supporting and coordinating IND-enabling activities
  • Working knowledge of small molecule drug discovery and development, nonclinical safety assessment, and GLP requirements, with scientific fluency sufficient to plan, question, and integrate the work.
  • Experience in targeted protein degradation, oncology, or immunology is an advantage.

Skills and attributes
  • Proficiency with project management tools and methods, including integrated timelines, critical path analysis, and resource planning (e.g., MS Project, Smartsheet, Planisware, or equivalent). Familiarity with AI tools a plus.
  • Exceptional organizational skills and attention to detail, with the judgment to know what matters and what does not.
  • Clear, concise written and verbal communication; able to present status and risk to senior leadership without embellishment.
  • Ability to influence and drive accountability without direct authority across a group of senior, highly experienced scientists.
  • Comfort with ambiguity and shifting priorities in a fast-moving discovery environment.

Reporting and Location
  • Reporting to SVP of Nonclinical Toxicology, Based at Nurix Therapeutics, Brisbane, CA, with on-site presence expected to support close partnership with laboratory and program teams.

Fit with Nurix Culture and Values
  • Strong team orientation; highly collaborative
  • Solutions and results-oriented focus
  • Hands-on approach; resourceful and open to diverse points of view

Salary Range: $220,700 - $252,667

Location: Brisbane, CA - Onsite

About Nurix

Nurix Therapeutics is a biotechnology company that is focused on the discovery, development, and commercialization of small molecule therapies that modulate the ubiquitin proteasome system (UPS) for the treatment of cancer and other diseases. The company's proprietary drug discovery platform is based on the use of DNA-encoded libraries (DELs) to identify small molecules that selectively bind to E3 ligases, which are key enzymes in the UPS. Nurix's lead drug candidate, NX-2127, is a first-in-class small molecule inhibitor of the CBL-B E3 ligase that is being developed for the treatment of solid tumors and hematological malignancies. The company was founded in 2013 and is headquartered in San Francisco, California.
Learn more about Nurix
Size
135 employees
Market Cap
$486 million
Industry
Net Income
-$43.2 million
Founded
2009
Revenue
$17.8 million
NASDAQ

Similar Jobs

More Jobs at Nurix

More Pharmaceuticals & Biotech Jobs

Find similar Director, Nonclinical Toxicology Operations jobs: